Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Learn wealth building tips from financial experts that can help you enhance your financial strategy and secure your future.
19,767 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
CoreWeave tumbled in morning trading as a legal case, insider sales and high leverage raise questions about its path ...
June payroll gains undershot forecasts, with revisions cooling prior months and participation slipping. The report le...
Bank ETFs offer a clean way to express a view on interest rates and the health of the U.S. economy. This guide explai...
Netflix stock flirting with a pivotal price level has investors weighing a potential decade-long opportunity against ...
Medicare surcharges tied to income jump in 2026, placing retirees in the irmaa five income brackets. Crossing the fir...
European lawmakers are pushing for an ethics inquiry into FIFA chief Gianni Infantino after allegations that politica...
The CFPB will publish an RFI in the Federal Register to solicit input on potential changes to TRID disclosures, resci...
The Federal Reserve unveiled five task forces led by academics and business leaders to reevaluate policy decision-mak...
AscendEX has halted most platform services after failing to secure MiCA authorization. The firm warns withdrawals may...
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
A July 12 KBW report argues artificial intelligence will fortify the industry’s largest lenders rather than upend the...